The novel lutecium‐based rare earth nanoparticles RENPs offer the potential for imaging‐guided tumor delineation with CXCR4 target, radio‐sensitization with ROS production and tumor microenvironment immune activation with immunogenic cell death and immune cell recruitment. Here, CXCR4 is linked to neoplasm.